Granules Pharma incorporates wholly owned subsidiary in Canada Written By Ruchika Sharma27 Nov 2025 2:33 PM ISTTelangana: Granules India has announced that Granules Pharmaceuticals, a Wholly Owned foreign subsidiary of the Company, has incorporated...
Panacea Biotec CFO Devender Gupta resigns, Amit Gupta to oversee finance function Written By Ruchika Sharma27 Nov 2025 12:30 PM ISTPunjab: Panacea Biotec has announced the resignation of Devender Gupta, Chief Financial Officer and Head Information Technology, who also...
Biocon Biologics Bengaluru facility classified as VAI by USFDA Written By Ruchika Sharma27 Nov 2025 11:33 AM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (FDA) CDER-OC, Office of Manufacturing Quality, has classified Biocon...
PharmEasy Slapped Rs 2 Lakh Fine for Auto-Add Subscription Practice Written By Parthika Patel26 Nov 2025 7:01 PM ISTNew Delhi: Taking strong action against deceptive online checkout designs, the Central Consumer Protection Authority (CCPA) has imposed a Rs 2 lakh...
DoP Shortlists Patented, Unlaunched Drugs for Global Tender Exemption, See Full List Written By Susmita Roy26 Nov 2025 6:48 PM ISTNew Delhi: In a move that could significantly reshape India's pharmaceutical procurement landscape, the Department of Pharmaceuticals (DoP) has issued...
Intas Pharma Gets CDSCO Panel Nod to Conduct Phase I Trial of Pertuzumab, Trastuzumab Solution for Injection Written By Susmita Roy26 Nov 2025 6:32 PM ISTNew Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Intas...
Abbott begins medical device correction for certain glucose monitors in US Written By Ruchika Sharma26 Nov 2025 4:30 PM ISTAbbott Park, III: Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United...
AstraZeneca Imfinzi gets USFDA okay for early gastric and gastroesophageal cancers Written By Ruchika Sharma26 Nov 2025 3:35 PM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin,...
Zydus Lifesciences strikes US licensing deal with RK Pharma for novel oncology supportive care injectable Written By Ruchika Sharma26 Nov 2025 2:29 PM ISTAhmedabad: Zydus Lifesciences, a global healthcare company, has announced that it has entered into an exclusive licensing and commercialization ...
Eris Lifesciences to buy balance 30 percent stake in Swiss Parenterals for Rs 423 crore Written By Ruchika Sharma26 Nov 2025 1:52 PM ISTMumbai: Eris Lifesciences Limited has announced that its Board of Directors has approved the acquisition of the balance 30 percent stake in Swiss...
Sanofi-Regeneron Dupixent approved in EU for chronic spontaneous urticaria Written By Ruchika Sharma26 Nov 2025 1:00 PM ISTParis: Sanofi has announced that the European Commission has approved Dupixent (dupilumab) for the treatment of moderate-to-severe chronic...
India well positioned to evolve as innovation led pharma nation over next 5 years: CDSCO Written By Ruchika Sharma26 Nov 2025 12:29 PM ISTNew Delhi: India is well-positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five...
